News Viking Therapeutics, Inc.

Equities

VKTX

US92686J1060

Real-time Estimate Cboe BZX Other stock markets 03:55:34 2024-06-05 pm EDT			5-day change	1st Jan Change
59.14 ^USD	+5.18%		-7.16%	+218.33%

Jun. 04	Health Care Climbs on Defensive Bias - Health Care Roundup	DJ
Jun. 04	Sector Update: Health Care Stocks Steady Pre-Bell Tuesday	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Health Care Climbs on Defensive Bias - Health Care Roundup	Jun. 04	DJ
Sector Update: Health Care Stocks Steady Pre-Bell Tuesday	Jun. 04	MT
Viking Therapeutics Reports 'Positive' 52-Week Results for NASH Drug; Shares Rise Pre-Bell	Jun. 04	MT
Transcript : Viking Therapeutics, Inc. - Special Call	Jun. 04
Viking Therapeutics Announces Positive 52-Week Histologic Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH)	Jun. 04	PR
Viking Therapeutics Announces Positive 52-Week Histologic Data from Phase 2B Voyage Study of Vk2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis	Jun. 04	CI
Viking Therapeutics to Participate at Upcoming Investor Conferences	May. 30	PR
Raymond James Upgrades Viking Therapeutics to Strong Buy From Outperform	May. 17	MT
North American Morning Briefing : The "Everything -2-	May. 17	DJ
Viking Therapeutics Insider Sold Shares Worth $4,986,008, According to a Recent SEC Filing	May. 06	MT
Wall St set to open sharply higher on soft jobs data	May. 03	RE
Amgen shares jump after teasing weight-loss drug data, rivals slip	May. 03	RE
Viking Therapeutics Insider Sold Shares Worth $22,136,474, According to a Recent SEC Filing	May. 03	MT
Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday	Apr. 25	MT
Viking Therapeutics Q1 Loss Widens; Shares Fall After Hours	Apr. 24	MT
Transcript : Viking Therapeutics, Inc., Q1 2024 Earnings Call, Apr 24, 2024	Apr. 24
Viking Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
6 Stocks Positioned to Soar as Investors Focus on MASH	Apr. 22	AQ
Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024	Apr. 17	PR
Health Care Falls as Risk Aversion Weighs on Obesity Drug Makers -- Health Care Roundup	Apr. 12	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Viking Therapeutics, Inc.

Equities

VKTX

US92686J1060

Summary

Filters